MX9207407A - IMPROVING THE BIOAVAILABILITY OF PROTEOLITICALLY LABIL THERAPEUTIC AGENTS. - Google Patents

IMPROVING THE BIOAVAILABILITY OF PROTEOLITICALLY LABIL THERAPEUTIC AGENTS.

Info

Publication number
MX9207407A
MX9207407A MX9207407A MX9207407A MX9207407A MX 9207407 A MX9207407 A MX 9207407A MX 9207407 A MX9207407 A MX 9207407A MX 9207407 A MX9207407 A MX 9207407A MX 9207407 A MX9207407 A MX 9207407A
Authority
MX
Mexico
Prior art keywords
proteolitically
labil
bioavailability
improving
therapeutic agents
Prior art date
Application number
MX9207407A
Other languages
Spanish (es)
Inventor
Gordon L Amidon
Glen D Leesman
Patrick J Sinko
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MX9207407A publication Critical patent/MX9207407A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2207—Gastrins; Cholecystokinins [CCK]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Botany (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX9207407A 1991-12-18 1992-12-17 IMPROVING THE BIOAVAILABILITY OF PROTEOLITICALLY LABIL THERAPEUTIC AGENTS. MX9207407A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81059391A 1991-12-18 1991-12-18

Publications (1)

Publication Number Publication Date
MX9207407A true MX9207407A (en) 1993-06-01

Family

ID=25204183

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9207407A MX9207407A (en) 1991-12-18 1992-12-17 IMPROVING THE BIOAVAILABILITY OF PROTEOLITICALLY LABIL THERAPEUTIC AGENTS.

Country Status (12)

Country Link
EP (1) EP0617626A1 (en)
JP (1) JPH06510796A (en)
AU (1) AU3058392A (en)
CA (1) CA2125400A1 (en)
FI (1) FI942938A (en)
HU (1) HUT69785A (en)
IL (1) IL104048A0 (en)
MX (1) MX9207407A (en)
NO (1) NO942323L (en)
PT (1) PT101135A (en)
WO (1) WO1993011799A1 (en)
ZA (1) ZA929761B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR950703333A (en) * 1992-10-02 1995-09-20 알렌 제이. 스피겔 Pharmaceutical Compositions Containing Nonionic Surfactants
AU7273494A (en) * 1993-09-01 1995-03-22 Pfizer Inc. Pharmaceutical compositions containing anionic surfactants
US6852690B1 (en) 1995-08-22 2005-02-08 Amylin Pharmaceuticals, Inc. Method and composition for enhanced parenteral nutrition
DE19530865A1 (en) * 1995-08-22 1997-02-27 Michael Dr Med Nauck Active ingredient and agent for parenteral nutrition
MXPA02007202A (en) * 2000-01-27 2003-09-22 Peros Syst Mes Technologies In Composition for intestinal delivery.
GB0015921D0 (en) * 2000-06-30 2000-08-23 Nat Biolog Standards Board Improvements in or relating to stabilisation of substances
CL2008001640A1 (en) * 2007-06-08 2008-11-07 Bergen Teknologioverforing As Use of hydroxyproline to prepare an alloy composition intended to promote the growth of an animal, such as fish, birds and mammals.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4537769A (en) * 1982-04-06 1985-08-27 American Cyanamid Company Stabilization of influenza virus vaccine
IL68769A (en) * 1983-05-23 1986-02-28 Hadassah Med Org Pharmaceutical compositions containing insulin for oral administration
US4774089A (en) * 1985-06-14 1988-09-27 Albion International, Inc. Stimulation of gonadotropic hormones with mineral mixtures containing amino acid chelates
MY103189A (en) * 1986-10-31 1993-05-29 Pfizer Nor-statine and nor-cyclostatine polypeptides
DE3887494T2 (en) * 1987-11-13 1994-05-19 Smithkline Beecham Farma Medicines containing a calcitonin and a glycyrrhizinate as absorption promoter.
EP0341661A3 (en) * 1988-05-11 1991-05-02 The Du Pont Merck Pharmaceutical Company Peptide-drug compositions containing alpha-aminoboronic acid derivatives
DD273980B5 (en) * 1988-07-12 1994-04-14 Berlin Chemie Ag Process for the preparation of insulin preparations for rectal use
GB8822857D0 (en) * 1988-09-29 1988-11-02 Patralan Ltd Pharmaceutical formulations
DK546289D0 (en) * 1989-11-02 1989-11-02 Danochemo As carotenoid

Also Published As

Publication number Publication date
PT101135A (en) 1994-03-31
AU3058392A (en) 1993-07-19
HUT69785A (en) 1995-09-28
EP0617626A1 (en) 1994-10-05
HU9401824D0 (en) 1994-09-28
NO942323D0 (en) 1994-06-17
CA2125400A1 (en) 1993-06-24
WO1993011799A1 (en) 1993-06-24
FI942938A0 (en) 1994-06-17
FI942938A (en) 1994-06-17
IL104048A0 (en) 1993-05-13
NO942323L (en) 1994-06-17
ZA929761B (en) 1994-06-17
JPH06510796A (en) 1994-12-01

Similar Documents

Publication Publication Date Title
FI906367A0 (en) THERAPEUTIC NUCLEOSIDER.
FI913899A0 (en) THERAPEUTIC AEROSOLBLANDNINGAR.
MX9102473A (en) PHARMACEUTICAL AGENTS.
DE59001306D1 (en) WHIRLPOOL BATHTUB.
FI904854A0 (en) THERAPEUTIC NUCLEOSIDER.
FI930674A0 (en) THERAPEUTIC AEMNEN
MX9207407A (en) IMPROVING THE BIOAVAILABILITY OF PROTEOLITICALLY LABIL THERAPEUTIC AGENTS.
FI923486A0 (en) THERAPEUTIC AEMNEN.
FI931071A0 (en) THERAPEUTIC AEMNEN
FI920701A0 (en) ANORDNING FOER THERAPEUTIC TRYCK- BEHANDLING.
FI910753A0 (en) THERAPEUTIC NUCLEOCIDER.
FI923528A (en) THERAPEUTIC AEMNEN.
MX9204709A (en) THERAPEUTIC AGENTS.
FI912852A0 (en) THERAPEUTIC DECAPEPTIDER.
NO911475D0 (en) Crutches.
ITTO920591A1 (en) PROCEDURE FOR THE PREPARATION OF N-PHOSPHONOMETHYLGLYCIN.
ITRM920099U1 (en) FUNERARY LOCULO.
NO901573L (en) THERAPEUTIC AGENTS.
NO901574L (en) THERAPEUTIC AGENTS.
ES1021209Y (en) PERFECTED SAUNA.
NO912208D0 (en) BATHTUB.
ATE88624T1 (en) WHIRLPOOL BATHTUB.
NO923037L (en) THERAPEUTIC AGENTS
NO910042D0 (en) STAIRCASE.
SE8900916D0 (en) AID FOR THE DISABLED